Abstract
We report a case of methotrexate-induced pericarditis and pericardial effusion in a 22-year-old pregnant woman. These complications have not previously been described as isolated phenomena associated with methotrexate therapy.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Akoun G. M., Mayaud C. M., Touboul J. L., Denis M. F., Milleron B. J., Perrot J. Y. Use of bronchoalveolar lavage in the evaluation of methotrexate lung disease. Thorax. 1987 Sep;42(9):652–655. doi: 10.1136/thx.42.9.652. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lehne G., Lote K. Pulmonary toxicity of cytotoxic and immunosuppressive agents. A review. Acta Oncol. 1990;29(2):113–124. doi: 10.3109/02841869009126530. [DOI] [PubMed] [Google Scholar]
- Massin F., Coudert B., Marot J. P., Foucher P., Camus P., Jeannin L. La pneumopathie du méthotrexate. Rev Mal Respir. 1990;7(1):5–15. [PubMed] [Google Scholar]
- Twohig K. J., Matthay R. A. Pulmonary effects of cytotoxic agents other than bleomycin. Clin Chest Med. 1990 Mar;11(1):31–54. [PubMed] [Google Scholar]